Search Results

Containing any of the words

Only of the type

(SG-1811-27-H) Oscor Inc. Issues Recall of TB Temporary Bipolar Pacing Lead (Unshrouded 2 mm Pins Models) Medical Report

Dr. Chungkeun Lee Speakers

Initiative for Companies to Register Unregistered or Unavailable Pharmaceutical Products Information List

O-SEMA-Fast: A research study to understand how oral semaglutide works in people with type 2 diabetes who plan to fast during Ramadan in the United Arab Emirates, Saudi Arabia, and Kuwait Drug Clinical Trial

A Phase 3, randomized, double-blind, placebo-controlled, parallel-group, 3-arm, multinational, multicenter study to evaluate the efficacy and safety of amlitelimab by subcutaneous injection in participants aged 18 years and older with moderate-to-severe atopic dermatitis (AD) who are on background topical corticosteroids and have had an inadequate response to prior biologic therapy or oral Janus Kinase (JAK) inhibitor treatment Drug Clinical Trial

SFDA Drug Sector Launches the Electronic Drug Clearance System for Registered Drugs (IBRCS) News

Alert about counterfeit product named Xiaokeshuping Jiangtangning Jiaonang capsules Warnings

Roundtable Connects SFDA with EU Officials and Business Leaders in Brussels News

Announcing the release of the second version of the electronic reporting system for adverse drug reaction Circulars

Randomized, four-way, four-period, single oral dose, open-label, crossover, bioequivalence study to compare Tacrolimus Immediate-release capsules (5 mg tacrolimus) versus Prograf® Immediate-release capsules (5 mg tacrolimus), in healthy subjects under fasting conditions. Drug Clinical Trial